Introduction:

Heberprot-P is a treatment that has proved to be effective in the treatment of diabetic foot ulcers.

Objective:

to characterize the evolution of the elderly with diabetic foot ulcers treated with Heberprot-P in Pinar de Rio.

Methods:

an observational, descriptive, longitudinal and retrospective study was carried out in the elderly treated with Heberprot-P for presenting diabetic foot ulcers in the period 2017-2020. The target group comprised 140 patients, and all of them were studied. Descriptive statistics was applied using absolute and relative percentage frequencies.

Results:

it was found a predominance of female patients (55,72 %), of the age group between 60 and 69 years (60 %) and with neuro-infectious diabetic foot (67,14 %). Ulcer infection was detected in 10 patients (7,1 %) and was associated with lack of granulation (p=0,003; OR=16.11; 95%CI=1.90-726.03). Amputation was required in 13,6 % of patients. An association was found between non-granulation and the requirement for amputation (p<0,05); 37,9 % of the patients presented some adverse response to the administration of Heberprot-P.

Conclusions:

the treatment with Heberprot-P showed encouraging results. The presence of adverse events was relatively high, being these of low repercussions, which ratifies Heberprot-P as an effective and safe treatment to accelerate the healing of diabetic foot ulcers and prevent the need for amputation.

        · resumo em Espanhol     · texto em Espanhol